Physician profile
Stuart L Bursten
NPI 1164494696
$1,055.19
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2022: $341 · 2023: $390 · 2024: $42.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $177.58 | 2022-2023 | Vraylar |
| Otsuka America Pharmaceutical, INC. | $119.19 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $95.46 | 2019-2024 | Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $94.69 | 2022 | |
| Lilly USA, LLC | $80.67 | 2022-2023 | Mounjaro |
| Exact Sciences Corporation | $70.77 | 2023 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $59.83 | 2022 | |
| Pfizer INC. | $52.25 | 2023 | |
| Nevro Corp. | $41.86 | 2022-2023 | Senza |
| Idorsia Pharmaceuticals US INC | $30.62 | 2023 | Quviviq |
| Mallinckrodt Enterprises LLC | $27.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.89 | 2024 | |
| Lucid Diagnostics INC. | $24.21 | 2023 | |
| Hologic Sales and Service, LLC | $23.88 | 2022 | |
| Opko Pharmaceuticals, LLC | $23.86 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.11 | 2019 | |
| Vifor Pharma, INC. | $18.74 | 2019 | |
| Novo Nordisk INC | $17.34 | 2023 | Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $16.60 | 2022 | |
| Fresenius USA Marketing, INC. | $16.46 | 2019 | |
| Akebia Therapeutics INC | $16.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Bursten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.